Monitor for potential selling pressure as stockholders may begin offloading shares; however, no immediate financial impact to the company as it receives no proceeds from resales. Watch for warrant exercises, which could bring nominal cash inflows.
Price Chart
Executive Summary
Ovid Therapeutics' shelf registration (S-3) has become effective, allowing the company and selling stockholders to offer up to 29,856,031 shares, including common shares and shares issuable upon exercise of pre-funded warrants, from a prior private placement. The company will not receive proceeds from the resale, but may receive nominal amounts if warrants are exercised in cash.
Key Facts
- Shelf registration (S-3) effective as of April 24, 2026, under SEC file number 333-295218
- Registration covers up to 29,856,031 shares, including 19.15 million common shares and 10.7 million shares issuable upon exercise of pre-funded warrants
- Shares were issued in a private placement on October 2, 2025
- Selling stockholders will resell the shares; company will not receive proceeds from the resale
- Company may receive nominal proceeds if warrants are exercised in cash
Financial Impact
Potential dilution overhang from up to 29.86 million shares eligible for resale, but no immediate dilution as company does not issue new shares in resale
Risk Factors
- Potential share price pressure from large volume of resalable shares
- Dilution risk if warrants are exercised and new shares are issued
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001333 |
| Document: 9999999995-26-001333-index.html | 9999999995-26-001333 |
| Document: 9999999995-26-001333.txt | 9999999995-26-001333 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 10w ago | 144 | $2.89 | awaiting T+60 | — | $2.22 (−23.18%) |
Jul 8, 2026 15w ago | 8-K | $2.73 $2.49 | ▼ −8.79% | ▼ −11.10% | $2.22 (−18.68%) |
Jun 3, 2026 20w ago | 8-K | $2.39 $2.93 | ▲ +22.59% | ▲ +20.10% | $2.22 (−7.11%) |
May 12, 2026 24w ago | Press Release | $2.87 $2.65 | ▼ −7.67% | ▼ −12.05% | $2.22 (−22.65%) |
Apr 27, 2026 26w ago | EFFECT | $2.69 $2.38 | ▼ −11.52% | ▼ −16.30% | $2.22 (−17.47%) |
Apr 21, 2026 26w ago | S-3 | $2.66 $2.44 | ▼ −8.27% | ▼ −13.05% | $2.22 (−16.54%) |
Apr 20, 2026 27w ago | 8-K | $2.89 $2.49 | ▼ −13.84% | ▼ −20.62% | $2.22 (−23.18%) |
Mar 18, 2026 31w ago | 8-K | $2.30 $2.21 | ▼ −3.91% | ▼ −15.44% | $2.22 (−3.48%) |
Mar 18, 2026 31w ago | Press Release | $2.30 $2.21 | ▼ −3.91% | ▼ −15.44% | $2.22 (−3.48%) |
Mar 18, 2026 31w ago | Press Release | $2.30 $2.21 | ▼ −3.91% | ▼ −15.44% | $2.22 (−3.48%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers